These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14599686)

  • 1. Mapping of conformational epitopes on capsid protein VP2 of infectious bursal disease virus by fd-tet phage display.
    Cui X; Nagesha HS; Holmes IH
    J Virol Methods; 2003 Dec; 114(1):109-12. PubMed ID: 14599686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of crucial residues of conformational epitopes on VP2 protein of infectious bursal disease virus by phage display.
    Cui X; Nagesha HS; Holmes IH
    J Virol Methods; 2003 Apr; 109(1):75-83. PubMed ID: 12668271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus.
    Letzel T; Coulibaly F; Rey FA; Delmas B; Jagt E; van Loon AA; Mundt E
    J Virol; 2007 Dec; 81(23):12827-35. PubMed ID: 17881448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping.
    Wang XN; Zhang GP; Zhou JY; Feng CH; Yang YY; Li QM; Guo JQ; Qiao HX; Xi J; Zhao D; Xing GX; Wang ZL; Wang SH; Xiao ZJ; Li XW; Deng RG
    Viral Immunol; 2005; 18(3):549-57. PubMed ID: 16212534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus.
    Yamaguchi T; Iwata K; Kobayashi M; Ogawa M; Fukushi H; Hirai K
    Arch Virol; 1996; 141(8):1493-507. PubMed ID: 8856029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotypic antibody specific for an infectious bursal disease virus-neutralizing monoclonal antibody does not interfere with the virus infection.
    Yamaguchi T; Igusa A; Setiyono A; Fukushi H; Hirai K
    Arch Virol; 2002 Oct; 147(10):2017-23. PubMed ID: 12376762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus.
    Schnitzler D; Bernstein F; Müller H; Becht H
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1563-71. PubMed ID: 7688411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time RT-PCR analysis of two epitope regions encoded by the VP2 gene of infectious bursal disease viruses.
    Mickael CS; Jackwood DJ
    J Virol Methods; 2005 Sep; 128(1-2):37-46. PubMed ID: 16023522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimaeric VP2 proteins from infectious bursal disease virus containing the N-terminal M2e of H9 subtype avian influenza virus induce neutralizing antibody responses to both viruses.
    Tang Y; Gong Y; Wang Y; Wu P; Liu Y; Lu J; Gao F; Chen T; Hou F; Hou J
    Avian Pathol; 2013; 42(3):260-7. PubMed ID: 23607544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of linear epitopes recognized by monoclonal antibodies with gene-fragment phage display libraries.
    Petersen G; Song D; Hügle-Dörr B; Oldenburg I; Bautz EK
    Mol Gen Genet; 1995 Dec; 249(4):425-31. PubMed ID: 8552047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified activity of a VP2-located neutralizing epitope on various vaccine, pathogenic and hypervirulent strains of infectious bursal disease virus.
    Eterradossi N; Toquin D; Rivallan G; Guittet M
    Arch Virol; 1997; 142(2):255-70. PubMed ID: 9125042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.
    Huang Z; Elankumaran S; Yunus AS; Samal SK
    J Virol; 2004 Sep; 78(18):10054-63. PubMed ID: 15331738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains.
    Heine HG; Haritou M; Failla P; Fahey K; Azad A
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1835-43. PubMed ID: 1651980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against very virulent infectious bursal disease virus using recombinant T4 bacteriophage displaying viral protein VP2.
    Cao YC; Shi QC; Ma JY; Xie QM; Bi YZ
    Acta Biochim Biophys Sin (Shanghai); 2005 Oct; 37(10):657-64. PubMed ID: 16215632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus.
    Oppling V; Müller H; Becht H
    Arch Virol; 1991; 119(3-4):211-23. PubMed ID: 1715158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus.
    Wang YS; Fan HJ; Li Y; Shi ZL; Pan Y; Lu CP
    Vaccine; 2007 May; 25(22):4447-55. PubMed ID: 17445956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of epitopes for virus-neutralizing monoclonal antibodies to Ross River virus E2 using phage-displayed random peptide libraries.
    Davies JM; Cai YP; Weir RC; Rowley MJ
    Virology; 2000 Sep; 275(1):67-76. PubMed ID: 11017788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens.
    Vakharia VN; Snyder DB; He J; Edwards GH; Savage PK; Mengel-Whereat SA
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1201-6. PubMed ID: 8389805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain variability and localization of important epitopes on the major structural protein (VP2) of infectious pancreatic necrosis virus.
    Heppell J; Tarrab E; Lecomte J; Berthiaume L; Arella M
    Virology; 1995 Dec; 214(1):40-9. PubMed ID: 8525637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of antigenic regions on VP2 of African horsesickness virus serotype 3 by using phage-displayed epitope libraries.
    Bentley L; Fehrsen J; Jordaan F; Huismans H; du Plessis DH
    J Gen Virol; 2000 Apr; 81(Pt 4):993-1000. PubMed ID: 10725425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.